Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of immunotherapy-based combination therapy.
Epistemonikos ID: fd851a1de58ba5f2c0991b0dc4ae00e416361859
First added on: Feb 19, 2024